首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 62 毫秒
1.
宋内I相抗原和霍乱CT—B共表达的免疫保护效果观察   总被引:3,自引:0,他引:3  
将编码宋内氏痢疾菌(Shigella sonnei)l相O抗原的基因和霍乱弧菌(Vibrio cholerae)的CT—B基因克隆至带asd基因的质粒PYA248.得重组质粒PMGLl05。将该重组质粒转入asd基因缺失的减毒伤寒沙门氏茵X4072.构成了一个不带抗药性基因的载体-宿主平衡致死景统。一系列实验表明.该重组苗X4072(PMGLl05)能稳定地表达宋内I相O抗原和霍乱弧菌的CT-B抗原.小鼠免疫保护实验表明,该重组菌对有毒的宋内氏I相痢疾杆菌及霍乱弧菌的攻击均具有良好保护作用。  相似文献   

2.
编码霍乱CT—B和LPSO抗原的基因与载体质粒pYA248重组后,转入△cya△crp △ asd减毒鼠伤寒疫苗株x4072,构建成无药物抗性、带双价抗原的工程菌株x4072(pMG306)。该菌株能分泌表达特异的霍乱CTB抗原,并且在菌体表面同时表达霍乱和鼠伤寒的。抗原。小鼠腹腔免疫和攻击试验表明该菌苗株对霍乱毒株的攻击具有良好的保护作用。本研究为新型霍乱/鼠伤寒双价口服活疫苗的构建打下了基础。  相似文献   

3.
本文采用超声破碎TritonX—100和超速离心技术提取了鼠伤寒杆菌(Salmonellatyphimurium,STM)的外膜蛋白(Outermembraneproteins,OMPs),并发现OMPs中脂多糖LPS的含量约为5%,OMPs经SDS—PAGE显示10余条蛋白带。对OMPs诱发BALB/C小鼠产生典型迟发型变态反应DTH和IL—2的水平进行了检测。经腹腔免疫的小鼠用500LD50鼠伤寒杆菌(50115)攻击,100%可得到保护;用500LD50伤寒杆菌(E686)攻击,33.3%可得到交叉保护。免疫BALB/C小鼠的T淋巴细胞,经尾静脉注射给非免疫小鼠,可使后者得到85.7%的被动免疫保护,上述结果说明OMPs能诱发BALB/C小鼠细胞免疫和保护性免疫,并提示成为分子疫苗的可能性。  相似文献   

4.
本文利用基因重组的方法,将宋内I相O抗原基因以及霍乱毒素B亚单位基因(ctx-B)克隆至带链球菌的asd基因的表达载体,然后转化至asd-痢疾菌苗株福氏2aT32。脂多糖银染以及Westernblotting实验证实以上两基因都能在宿主菌中稳定表达。动物(小白鼠)保护实验表明,该重组菌对福氏2a、宋内氏痢疾菌的保护效率达100%,对霍乱弧菌的保护效率也达70%。该菌具有稳定、无抗生素标记、多价的特点。  相似文献   

5.
表达霍乱CT-B和LPS-O抗原的鼠伤寒菌苗株的构建   总被引:5,自引:0,他引:5  
将编码霍乱CT-B和LPS-O抗原的基因与载体质粒pYA248重组后,转入△cya△crp△asd减毒鼠伤寒疫苗株x4072构建成无药物抗性,带双价抗原的工程菌株x4072(pMG306)。该菌株能分泌表达特异的霍乱CT-B抗原,并且在菌体表面同时表达霍乱和鼠伤寒的O抗原。小鼠腹腔免疫和攻击试验表明该菌株对霍乱毒株的攻击具有良好的保护作用。本研究为新型献计霍乱/鼠伤寒双价口服活疫苗的构建打下了基础  相似文献   

6.
不耐热肠毒素(LT)和耐热肠毒素(ST)是产肠毒素大肠杆菌的主要致病因素,CS3为该菌的优势定居因子,是定居因子CFA/Ⅱ菌毛抗原的共有抗原组分。采用基因操作技术将编码CS3和融合肠毒素蛋白基因转化到减毒鼠伤寒沙门氏菌疫苗侯选株X4072中进行表达。用重组菌株口服免疫小鼠后,免疫动物能产生抗CS3、LT和ST的血清抗体。特别有意义的是,所产生的抗ST抗体能中和天然ST的生物活性。这一结果为研究载体疫苗防治肠毒素大肠杆菌腹泻疾病奠定了基础。  相似文献   

7.
本实验采用超声破碎、TritonX-100处理和超速离心技术提取了鼠伤寒沙门氏菌(Salmonellatyhimurium,STM)的外膜蛋白(Outermembraneproteins,OMPs),其中脂多糖(LPS)的含量约为5%。OMPs经SDS—PAGE显示10余条蛋白带。对OMPs诱发BALB/C小鼠产生典型的迟发型变态反应(DTH)进行了检测。经腹腔免疫的BALB/C小鼠用500LD50鼠伤寒沙门氏菌(50115)攻击,100%可得到保护;用500LD50伤寒杆菌(E686)攻击  相似文献   

8.
将编码Vi抗原的基因克隆到减毒的鼠伤寒沙门氏菌中组建的基因重组株Vi4072,以3×10~8CFU一次口服感染Balb/C小鼠,4天后按7,14,21,28,35,42,49,56,63,70天的间隔收集分离小鼠的集合淋巴结,肝,脾.鉴别是否有本菌出现,并检测血清和小肠匀浆液中的vi抗体.结果表明,感染后49天仍可从脾中分离到该菌;70天仍可从血清和小肠匀浆液中测出vi抗体。  相似文献   

9.
以提纯的鼠伤寒沙门氏菌8705染色体DNA为材料,经EcoR Ⅰ消化,过SepharcylS-400柱,得到大于400bp的酶切片段;然后随机克隆到质粒pGEM-3Zf(—)中,转化大肠杆菌LC2a(hag~-,recA~-);在氨苄青霉素平板上共得到6013个转化子,从中筛选出1个有动力的克隆,小量制备质粒DNA,经酶切电泳鉴定,该克隆的外源片段大小为15.3kb,将其命名为pGI4015。动力、动力抑制试验和Southern blot分子杂交试验证明pGI4015中载有鼠伤寒沙门氏菌Ⅰ相鞭毛蛋白基因fliC~I;利用其BamH Ⅰ和Sal Ⅰ位点删除与鞭毛蛋白表达无关的序列,构建亚克隆质粒pGI4015BS,使得fliC~I定位于更小的区域——3.8kb的BamH Ⅰ/Sal Ⅰ插入片段上。  相似文献   

10.
鼠伤寒沙门氏菌I相鞭毛蛋白基因fliC^i的克隆和鉴定   总被引:2,自引:0,他引:2  
  相似文献   

11.
A compositional sugar analysis was carried out on lipopolysaccharide (LPS) from Shigella sonnei form II in which a plasmid with cloned form I antigen genes had been introduced. The recipient form II strains contained galactose, glucose, heptose, glucosamine, and 2-keto-3-deoxyoctonic acid (KDO) (2: 3: 1: 2: 2) in its LPS, while the transformant form I LPS contained, besides these sugars, N-acetyl-L -altrosaminouronic acid as an additional sugar constituent, which is known to be one of the antigenic determinants of form I antigen.  相似文献   

12.
将含有编码Vi抗原ViaB基因片断的质粒转导进入宋内氏痢疾菌无毒株S7中,组建了重组菌株S7Vi。质粒电泳图谱显示重组菌株S7Vi中存在被转入的外源质粒带。重组株的生化特性没有改变。菌体凝集及Vi抗血清标记的SPA菌液凝集反应证明在重组株的菌体表面,同时表达了Vi抗原和宋内氏毒菌的O抗原。以5×10~8CFU、10×10~8CFU的重组株免疫近交系的LIBP小鼠,免疫小鼠对宋内氏毒株S63攻击的保护率为60%至90%,对伤寒毒株Ty2攻击的保护率为25%至40%。  相似文献   

13.
The detailed chemical structure of lipid A of Shigella sonnei phase II was elucidated. The lipid A backbone consists of a β-1,6-linked glucosamine disaccharide substituted with (mono) phosphates both at C-1 and C-4′. This was shown by selective degradation followed by 31P-NMR studies. C-4 and C-6′ were found to contain unsubstituted hydroxyl groups, the latter being the point of attachment of KDO as reported for other enterobacterial lipids A.The amino groups of the glucosamine disaccharide are substituted by 3-hydroxy fatty acids: 3-O-(14:0) 14:0 at the non-reducing glucosamine and 3-O-(12:0) 14:0 at the reducing glucosamine. In contrast to earlier reports, no ethanolamine or phosphodiester linkages were found in lipid A.  相似文献   

14.
Outbreaks of Shigella sonnei associated with contaminated water have been reported and methods for the simultaneous detection of Shigellae and enteroinvasive Escherichia coli in water samples have been developed with detection limits of 10(1)-10(2) CFU mL(-1) of water. Because 10(1)-10(2)Shigellae can cause disease, a more sensitive detection method as an addition to the existing methods for detection of Shigella sonnei in water samples is reported here. Initially, 33 Shigella sonnei and 72 non-Shigella sonnei isolates were tested and one primer pair was found capable of specifically amplifying a 369-bp insertion sequence 1 (IS1) fragment from all 33 Shigella sonnei isolates and one Shigella dysenteriae ATCC isolate by PCR. The detection method was developed, which included filtration of 50 mL of water through a membrane and application of PCR to the membrane using this primer pair. Environmental water samples with total bacterial numbers of 384-2.84 x 10(7) CFU L(-1) were collected and seeded with 13 Shigella sonnei and the Shigella dysenteriae ATCC isolates. Detection limits were determined as 1.7-24.7 and 270-8000 CFU per 50 mL of water, respectively, using this detection method.  相似文献   

15.
Expression of Shigella sonnei lipopolysaccharide in Vibrio cholerae   总被引:2,自引:0,他引:2  
Making use of a newly designed mobilizable suicide vector, the genetic determinants encoding Shigella sonnei lipopolysaccharide (LPS) were stably integrated into the chromosome of the live attenuated Vibrio cholerae vaccine strain CVD103-HgR. Expression studies showed that the production of complete S. sonnei O-polysaccharide (O-PS)-bearing LPS was limited in bivalent recombinant strains that were also proficient in the synthesis of the host-encoded Inaba O-PS. Conversely, high amounts of LPS carrying S. sonnei O-PS are produced in monovalent Inaba-deficient derivatives, even in those strains which do not co-express the compatible R1 LPS core. Thus, the non-enterobacterial V. cholerae LPS core efficiently acts as a receptor for covalent binding of S. sonnei O-PS provided that competition with the host O-PS is avoided. Expression of the R1 core interferes with cell division in recombinant V. cholerae without affecting other physiological properties of vaccine strain CVD103-HgR. Both monovalent and bivalent strains stimulated high serum-antibody titres specific for their respective O-serotype(s) when administered to rabbits. The potential of V. cholerae as an expression carrier for heterologous O-serotypes is discussed.  相似文献   

16.
AIMS: Antimicrobial resistance of Shigella sonnei from Malaysia was determined and subtyping was carried by pulsed-field gel electrophoresis (PFGE) to assess the extent of genetic diversity of these strains. METHODS AND RESULTS: A total of 62 isolates of S. sonnei from sporadic cases of shigellosis in different parts of Malaysia were studied by antimicrobial susceptibility test and PFGE. Approximately 35.5% of the strains showed resistance to three or more antimicrobial agents. Eight resistant phenotypes, i.e. RI to RVIII, was defined. Resistant phenotype RV and RVIII only appeared in year 2000. PFGE analysis with NotI and XbaI restriction showed that a great heterogeneity existed at the DNA level among Malaysian S. sonnei isolates. Fifty-eight NotI and 61 XbaI-PFGE profiles were observed in 63 S. sonnei isolates, including ATCC 11060 isolate. Drug sensitive isolates displayed very different profiles from drug-resistant isolates, with a few exceptions. Isolates of resistant phenotype RVI (SXTr.TETr.STRr) showed a greater similarity among each other compared with isolates of resistant phenotype RI and drug-sensitive isolates. CONCLUSION: Multi-drug-resistant S. sonnei were circulated in different parts of Malaysia and the emergence of new resistant phenotype was observed. Wide genetic variations among Malaysian S. sonnei were observed and the drug-sensitive strains could be differentiated from drug-resistant strains by PFGE. SIGNIFICANCE AND IMPACT OF THE STUDY: The present study verifies the usefulness of PFGE in characterizing and comparing strains of S. sonnei. Minor variations among S. sonnei isolates could be detected by PFGE.  相似文献   

17.
AIMS: To determine the efficacy of solar disinfection (SODIS) for enteric pathogens and to test applicability of the reciprocity law. METHODS AND RESULTS: Resistance to sunlight at 37 degrees C based on F99 values was in the following order: Salmonella Typhimurium>Escherichia coli>Shigella flexneri>Vibrio cholerae. While F90 values of Salm. Typhimurium and E. coli were similar, F99 values differed by 60% due to different inactivation curve shapes. Efficacy seemed not to be dependent on fluence rate for E. coli stationary cells. Sensitivity to mild heat was observed above a temperature of 45 degrees C for E. coli, Salm. Typhimurium and Sh. flexneri, while V. cholerae was already susceptible above 40 degrees C. CONCLUSIONS: Salmonella Typhimurium was the most resistant and V. cholerae the least resistant enteric strain. The reciprocity law is applicable for stationary E. coli cells irradiated with sunlight or artificial sunlight. SIGNIFICANCE AND IMPACT OF THE STUDY: Escherichia coli might not be the appropriate indicator bacterium to test the efficacy of SODIS on enteric bacteria and the physiological response to SODIS might be different among enteric bacteria. The applicability of the reciprocity law indicates that fluence rate plays a secondary role in SODIS efficacy. Stating inactivation efficacy with T90 or F90 values without showing original data is inadequate for SODIS studies.  相似文献   

18.
作者将霍乱弧菌O抗原及毒素B亚单位基因片段,经DNA体外重组技术,得到了能表达双价抗原的工程菌株1046(pMG305)。经GM1-ELISA分析表明该菌株能够表达特异的霍乱CT-B抗原,且能分泌到胞外,通过菌体凝集,全细胞O抗原酶联分析和血凝抑制试验表明在1046(pMG305)菌体表面表达了霍乱的O抗原,它的脂多糖O抗原通过SDS-PAGE电泳分析,显示它表达了霍乱LPS的特征区带。小鼠腹腔免疫后用霍乱弧菌毒株攻击表明,有良好的保护作用,因此1046(pMG305)可望成为霍乱活疫苗的候选株。  相似文献   

19.
试图通过提高质粒拷贝数来提高宋内I相O-抗原的表达水平,先将宋内I相O-抗原基因亚克隆至高拷贝的pUC18和pGEM3Z,但没能找到相应的阳性转化子,可能O-抗原基因在高拷贝质粒上表达水平太高对宿主产生毒性效应。再将其亚克隆至中等拷贝的pAT153,虽能找到阳性转化子,但表达水平仍不能满足以后实验的需要,表明质粒拷贝数与I相O-抗原的表达水平密切相关,要有效地表达宋内I相O-抗原,还需要寻找拷贝数  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号